Treatment of cutaneous leishmaniasis (CL) is a public health problem in endemic areas. The objective of the current study was to investigate the immunotherapeutic activities of the hydroalcoholic extract of Glycyrrhiza glabra (HEG) and glycyrrhizic acid (GA) in the treatment of Leishmania major (L. major)‐infected BALB/c mice. In this study, the effect of HEG and GA was checked in vitro on growth of L. major promastigote and amastigote using MTT assay and microscopic counting, respectively. For in vivo experiment, the lesion induced by L. major on BALB/c mice were treated intraperitoneally with HEG, GA, meglumine antimoniate or phosphate buffer saline (negative control) for one month. Then, the lesion development and the parasite burden of the lymph node was assessed, the cytokine response (IFN‐γ and IL‐4) to Leishmania antigens was evaluated using ELISA method. The results showed that HEG and GA significantly inhibited the growth of L. major promastigotes and amastigotes, the lesion development, parasite burden in the lymph nodes, level of IFN‐γ and the ratio of IFN‐γ/IL‐4 in HEG, GA and meglumine antimoniate‐treated mice were significantly higher compared with the negative control group, there was no difference between the HEG, GA and meglumine antimoniate group. It is concluded that hydroalcoholic extract of G. glabra and glycyrrhizic acid showed therapeutic and immunomodulatory effects on L. major‐infected BALB/c mice
Background: The complexity of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) makes the clinical course of the disease develop rapidly, causing severe and deadly complications. Identifying effective laboratory biomarkers able to predicting patients based on their risk. This study aimed to look for those serobiomarkers in hospitalized patients with Coronavirus Disease 2019 (COVID‐19). Materials and Methods: In this retrospective observational study, 114 patients with COVID-19, admitted to Valian hospital in Aligudarz, City, Iran from October to December 2020 were examined. The disease outcome was followed along with the hospital course of every patient at the time of analysis. Laboratory investigations of all patients were monitored at the time of admission. A comparative analysis was done between the survivors (n=73) and non-survivors (n=41). Statistical analysis was conducted using SPSS. Results: Of the 114 patients, 40.4% (n=41) were non-survivor, and there were significant differences in Hemoglobin (Hb), Hematocrit (Hct), Platelet (PLT), Alkaline Phosphatase (ALP), Total Bilirubin, Fasting Blood Suger (FBS), Total Iron-Binding Capacity (TIBC), Lactate Dehydrogenase (LDH), Blood Urea Nitrogen (BUN), Creatinine (Cr), Albumin (ALB), and C-Reactive Protein (CRP) between survivors and non-survivors. Conclusion: The laboratory parameters have fundamental roles in poor prognosis and mortality prediction rated among patients with COVID-19 in the first admission. Thus, it is highly recommended to collaborate among hematologists, health managers, and clinical especialists.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.